神経診断市場レポート：2030年までの動向、予測、競合分析

神経診断の動向と予測

世界の神経診断市場は、2024年から2030年までのCAGRが7.1%で、2030年までに推定127億米ドルに達すると予想されます。この市場の主な促進要因は、神経疾患や神経障害の有病率の増加、正確でタイムリーな疾患診断に対する患者の関心の高まり、神経変性疾患診断のためのゲノミクスとプロテオミクスの進歩です。世界の神経診断市場の将来は、病院・手術センター、神経学センター、外来医療センター、診断研究所・画像診断センター、研究所・学術研究所の各市場における機会が有望視されています。

神経診断市場の洞察

Lucintelは、外傷性脳損傷、認知症、パーキンソン病、ハンチントン病の有病率が上昇しているため、予測期間中も神経変性疾患が最大セグメントであり続けると予測しています。

北米はヘルスケアシステムが発達しており、最新の神経診断機器が医療関係者に広く受け入れられ、高度な神経診断技術へのアクセスが容易であるため、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.世界の神経診断市場は、2030年までに推定127億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の神経診断市場は、2024年から2030年にかけてCAGR 7.1%で成長すると予想されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、神経疾患や神経障害の有病率の増加、正確でタイムリーな疾患診断に対する患者の関心の高まり、神経変性疾患診断のためのゲノミクスとプロテオミクスの進歩です。

Q4.市場の主要セグメントは？

A4.世界の神経診断市場の将来は、病院・手術センター、神経学センター、外来医療センター、診断研究所・画像診断センター、研究所・学術研究所の各市場における機会が有望です。

Q5.市場の主要企業は？

A5.神経診断の主要企業は以下の通りです。

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon
• Hitachi
• Lifelines Neuro Company
• Natus Medical
• Hoffman-La Roche
• FUJIFILM Holdings
• Mitsar

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、外傷性脳損傷、認知症、パーキンソン病、ハンチントン病の有病率が上昇しているため、予測期間中、神経変性疾患が最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、ヘルスケアシステムが発達しており、最新の神経診断機器が医療関係者に広く受け入れられ、高度な神経診断技術へのアクセスが容易であるため、予測期間中も最大地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の神経診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の神経診断市場動向（2018-2023）と予測（2024-2030）
• 製品別の世界の神経診断市場
  • イントロダクション
  • 診断と画像システム
  • 臨床検査機器
  • 試薬と消耗品
• 状態別の世界の神経診断市場
  • 神経変性疾患
  • てんかん
  • 脳卒中
  • 頭痛障害
  • 睡眠障害
  • その他
• 最終用途別の世界の神経診断市場
  • 病院と手術センター
  • 神経センター
  • 外来診療センター
  • 診断研究所と画像センター
  • 調査と学術機関
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の神経診断市場
• 北米の神経診断市場
• 欧州の神経診断市場
• アジア太平洋の神経診断市場
• その他地域の神経診断市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界の神経診断市場の成長機会
  • 条件別の世界の神経診断市場の成長機会
  • 最終用途別の世界の神経診断市場の成長機会
  • 地域別の世界の神経診断市場の成長機会
• 世界の神経診断市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の神経診断市場の能力拡大
  • 世界の神経診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon
• Hitachi
• Lifelines Neuro Company
• Natus Medical
• Hoffman-La Roche
• FUJIFILM Holdings
• Mitsar

Neurodiagnostics Trends and Forecast

The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets. The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

A more than 150-page report is developed to help in your business decisions.

Neurodiagnostics by Segment

The study includes a forecast for the global neurodiagnostics by product, condition, end use, and region.

Neurodiagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Introduction
• Diagnostic And Imaging Systems
• Clinical Testing Instruments
• Reagents & Consumables

Neurodiagnostics Market by Condition [Shipment Analysis by Value from 2018 to 2030]:

• Neuro Degenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders
• Others

Neurodiagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals And Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes
• Others

Neurodiagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neurodiagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurodiagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurodiagnostics companies profiled in this report include-

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon
• Hitachi
• Lifelines Neuro Company
• Natus Medical
• Hoffman-La Roche
• FUJIFILM Holdings
• Mitsar

Neurodiagnostics Market Insights

Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Features of the Global Neurodiagnostics Market

Market Size Estimates: Neurodiagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurodiagnostics market size by product, condition, end use, and region in terms of value ($B).

Regional Analysis: Neurodiagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, condition, end use, and regions for the neurodiagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurodiagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the neurodiagnostics market size?

Answer: The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030.

Q2. What is the growth forecast for neurodiagnostics market?

Answer: The global neurodiagnostics market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the neurodiagnostics market?

Answer: The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

Q4. What are the major segments for neurodiagnostics market?

Answer: The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets.

Q5. Who are the key neurodiagnostics market companies?

Answer: Some of the key neurodiagnostics companies are as follows.

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon
• Hitachi
• Lifelines Neuro Company
• Natus Medical
• Hoffman-La Roche
• FUJIFILM Holdings
• Mitsar

Q6. Which neurodiagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

Q7. In neurodiagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neurodiagnostics market by product (introduction, diagnostic and imaging systems, clinical testing instruments, and reagents & consumables), condition (neuro degenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and others), end use (hospitals and surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, research laboratories & academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurodiagnostics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Neurodiagnostics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Neurodiagnostics Market by Product
  • 3.3.1: Introduction
  • 3.3.2: Diagnostic and Imaging Systems
  • 3.3.3: Clinical Testing Instruments
  • 3.3.4: Reagents & Consumables
• 3.4: Global Neurodiagnostics Market by Condition
  • 3.4.1: Neuro Degenerative Diseases
  • 3.4.2: Epilepsy
  • 3.4.3: Stroke
  • 3.4.4: Headache Disorders
  • 3.4.5: Sleep Disorders
  • 3.4.6: Others
• 3.5: Global Neurodiagnostics Market by End Use
  • 3.5.1: Hospitals and Surgery Centers
  • 3.5.2: Neurology Centers
  • 3.5.3: Ambulatory Care Centers
  • 3.5.4: Diagnostic Laboratories & Imaging Centers
  • 3.5.5: Research Laboratories & Academic Institutes
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Neurodiagnostics Market by Region
• 4.2: North American Neurodiagnostics Market
  • 4.2.1: North American Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.2.2: North American Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
• 4.3: European Neurodiagnostics Market
  • 4.3.1: European Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.3.2: European Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
• 4.4: APAC Neurodiagnostics Market
  • 4.4.1: APAC Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.4.2: APAC Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
• 4.5: ROW Neurodiagnostics Market
  • 4.5.1: ROW Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
  • 4.5.2: ROW Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Neurodiagnostics Market by Product
  • 6.1.2: Growth Opportunities for the Global Neurodiagnostics Market by Condition
  • 6.1.3: Growth Opportunities for the Global Neurodiagnostics Market by End Use
  • 6.1.4: Growth Opportunities for the Global Neurodiagnostics Market by Region
• 6.2: Emerging Trends in the Global Neurodiagnostics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Neurodiagnostics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurodiagnostics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GE Healthcare
• 7.2: Siemens Healthineers
• 7.3: Philips Healthcare
• 7.4: Canon
• 7.5: Hitachi
• 7.6: Lifelines Neuro Company
• 7.7: Natus Medical
• 7.8: Hoffman-La Roche
• 7.9: FUJIFILM Holdings
• 7.10: Mitsar